Home|DSIJArticleDetail

Low PE penny stock under Rs 5; Board likely to announce bonus shares, stock split and dividend!
Low PE penny stock under Rs 5; Board likely to announce bonus shares, stock split and dividend!

Low PE penny stock under Rs 5; Board likely to announce bonus shares, stock split and dividend!

The stock has a PE of 18.60x whereas the industry PE is 30x.

DSIJ Intelligence-1 Article rating: 3.8

Earum Pharmaceuticals has a market cap of Rs 36.82 crore. The company reported positive numbers in its both quarterly results and annual results. The stock has a PE of 18.60x whereas the industry PE is 30x.

Heavy buying witnessed in this penny stock under Rs 5; Board likely to announce bonus shares and stock split!
Heavy buying witnessed in this penny stock under Rs 5; Board likely to announce bonus shares and stock split!

Heavy buying witnessed in this penny stock under Rs 5; Board likely to announce bonus shares and stock split!

The stock has a 52-week high of Rs 3.68 and a 52-week low of Rs 1.52.

DSIJ Intelligence-1 Article rating: 3.8

Earum Pharmaceuticals Limited produces and distributes pharmaceutical products. The company offers tablets, capsules, ointments, creams, gels, powders, and syrup. Earum Pharmaceuticals markets its products globally.

Penny stock under Rs 5; Board likely to announce bonus shares, stock split and dividend!
Penny stock under Rs 5; Board likely to announce bonus shares, stock split and dividend!

Penny stock under Rs 5; Board likely to announce bonus shares, stock split and dividend!

The shares of the company saw a spurt in volume by more than 2.20 times on BSE.

DSIJ Intelligence-1 Article rating: 3.7

Earum Pharmaceuticals Limited produces and distributes pharmaceutical products. The Company offers tablets, capsules, ointments, creams, gels, powders, and syrup. Earum Pharmaceuticals markets its products globally.

DSIJ MINDSHARE

Mindshare7-Jun, 2025

Mindshare7-Jun, 2025

Mindshare7-Jun, 2025

Mindshare7-Jun, 2025

Penny Stocks7-Jun, 2025

Knowledge

Knowledge30-May, 2025

MF15-May, 2025

MF2-May, 2025

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

SEBI Registered Research Analyst Details:
Registered Name: DSIJ PRIVATE LIMITED
Type of registration: Non-Individual
Registration No.: INH000006396
Validity: Oct 05, 2018 - Perpetual
BSE Enlistment No. 5307

SEBI Registered Investment Adviser Details:
Registered Name: DSIJ PRIVATE LIMITED
Type of registration: Non-Individual
Registration No.: INA000001142
Validity: Aug 19, 2019 - Perpetual
BSE Enlistment No. 1346

Registered and Correspondence Office Address :
DSIJ PVT LTD. Office No - 409,
Solitaire Business Hub, Kalyani Nagar, Pune - 411006
Tel: +91 022-43476012/13/14/15 | Email: service@dsij.in
CIN No.: U22120MH2003PTC139276
GST No.: 27AACCR4303G1ZP

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR

Disclaimer: "Registration granted by SEBI, membership of BASL and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors"

Investment in securities market is subject to market risks. Read all the related documents carefully before investing.

Any act of copying, reproducing, or distributing the content whether wholly or in part, for any purpose without the permission of DSIJ is strictly prohibited and shall be deemed to be copyright infringement.

Disclosures | Terms & Conditions | Privacy Statement | WhiteList